Arix Bioscience PLC (ARIX) Notice of Investor Presentation 22-Jun-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.

-----------------------------------------------------------------------------------------------------------------------

Arix Bioscience plc

Notice of Investor Presentation

LONDON, 22 June 2022: Arix Bioscience plc ("Arix" or the "Company") (LSE: ARIX), announces that CEO, Robert Lyne, and Managing Director, Mark Chin, will be hosting a live presentation and Q&A session via the online platform, Investor Meet Company, at 1:00 p.m. BST on Wednesday 29 June 2022.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the 'Investor Meet Company' dashboard up until 9:00 a.m. on Tuesday 28 June 2022 or at any time during the live presentation. Investors can sign up to Investor Meet Company for free via: https://www.investormeetcompany.com/ arix-bioscience-plc/register-investor

Investors who already follow Arix on the Investor Meet Company platform will automatically receive an invitation to the event.

[ENDS]

Enquiries

For more information on Arix, please contact:

Arix Bioscience plc

+44 (0)20 7290 1050

ir@arixbioscience.com

Powerscourt Group

Sarah MacLeod, Ibrahim Khalil, Nick Johnson

+44 (0)20 7250 1446

arix@powerscourt-group.com

About Arix Bioscience plc

Arix Bioscience plc is a global venture capital company focused on investing in breakthrough biotechnology companies around cutting-edge advances in life sciences.

We collaborate with exceptional entrepreneurs and provide the capital, expertise, and global networks to help accelerate their ideas into important new treatments for patients. As a listed company, we are able to bring this exciting growth phase of our industry to a broader range of investors. www.arixbioscience.com

-----------------------------------------------------------------------------------------------------------------------

ISIN:           GB00BD045071 
Category Code:  MSCL 
TIDM:           ARIX 
LEI Code:       213800OVT3AHQCXNIX43 
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State 
Sequence No.:   169801 
EQS News ID:    1380689 
 
End of Announcement  EQS News Service 
=------------------------------------------------------------------------------------

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1380689&application_name=news

(END) Dow Jones Newswires

June 22, 2022 02:00 ET (06:00 GMT)

Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Oct 2023 to Dec 2023 Click Here for more Arix Bioscience Charts.
Arix Bioscience (LSE:ARIX)
Historical Stock Chart
From Dec 2022 to Dec 2023 Click Here for more Arix Bioscience Charts.